Executive Vice President, Chief Commercial Officer
Robert Azelby received an average compensation of $5,912,407 at Juno Therapeutics between 2015 and 2016.
|Non-Equity Incentive Plan||$132,800|
In 2016, Robert Azelby earned a total compensation of $1,912,225 as Executive Vice President, Chief Commercial Officer at Juno Therapeutics, Inc..
Azelby received $643,532 in option awards, which accounts for 33.65% of total compensation.
Azelby also received $132,800 in non-equity incentive plan, $409,413 in salary, $252,900 in stock awards and $473,580 in other compensation.